Survivin, a unique inhibitor of apoptosis (IAP) protein, has been shown to be overexpressed in malignancies compared to normal adult tissue.25 As this protein is overexpressed in tumour cells and embryonic cells but is undetectable in normal tissues, it is an attractive candidate for tumour‐targeted therapy.26 MiRNA‐214‐3p (miR‐214‐3p) can bind to survivin mRNA, which reduces the stability of survivin mRNA. Here, BIRC5 is linked to neoplasm.